Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 4 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9-15 months old Nepalese infants.
Vaccine. 2022 Sep 22;40(40):5828-5834. doi: 10.1016/j.vaccine.2022.08.034. Epub 2022 Sep 3.
Vaccine. 2022.
PMID: 36064672
Clinical Trial.
A Phase 3, Multicenter, Randomized, Controlled Trial to Evaluate Immune Equivalence and Safety of Multidose and Single-dose Formulations of Vi-DT Typhoid Conjugate Vaccine in Healthy Filipino Individuals 6 Months to 45 Years of Age.
Carlos JC, Tadesse BT, Borja-Tabora C, Alberto E, Ylade MC, Sil A, Kim DR, Ahn HS, Yang JS, Lee JY, Kim MS, Park J, Kwon SY, Kim H, Yang SY, Ryu JH, Park H, Shin JH, Lee Y, Kim JH, Mojares ZR, Wartel TA, Sahastrabuddhe S.
Carlos JC, et al.
Lancet Reg Health West Pac. 2022 May 30;24:100484. doi: 10.1016/j.lanwpc.2022.100484. eCollection 2022 Jul.
Lancet Reg Health West Pac. 2022.
PMID: 35664443
Free PMC article.
Item in Clipboard
Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose.
Capeding MR, Tadesse BT, Sil A, Alberto E, Kim DR, Park EL, Park JY, Yang JS, Eluru JR, Jo SK, Kim H, Yang SY, Ryu JH, Park H, Shin JH, Lee Y, Kim JH, Mojares ZR, Wartel TA, Sahastrabuddhe S.
Capeding MR, et al.
NPJ Vaccines. 2022 Jan 27;7(1):12. doi: 10.1038/s41541-022-00434-8.
NPJ Vaccines. 2022.
PMID: 35087084
Free PMC article.
Item in Clipboard
Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.
Kumar Rai G, Saluja T, Chaudhary S, Tamrakar D, Kanodia P, Giri BR, Shrestha R, Uranw S, Kim DR, Yang JS, Park IY, Kyung SE, Vemula S, Reddy E J, Kim B, Gupta BP, Jo SK, Ryu JH, Park HK, Shin JH, Lee Y, Kim H, Kim JH, Mojares ZR, Wartel TA, Sahastrabuddhe S.
Kumar Rai G, et al.
Lancet Infect Dis. 2022 Apr;22(4):529-540. doi: 10.1016/S1473-3099(21)00455-2. Epub 2021 Dec 20.
Lancet Infect Dis. 2022.
PMID: 34942090
Free PMC article.
Clinical Trial.
Item in Clipboard
Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics.
Haselbeck AH, Tadesse BT, Park J, Gibani MM, Espinoza LMC, Abreu A, Van Rensburg C, Owusu-Ansah M, Twuamsi-Ankrah S, Owusu M, Aguna I, Picot V, Jeon H, Higginson E, Park S, Mojares ZR, Im J, Carey ME, Khanam F, Tonks S, Dougan G, Kim D, Sugimoto J, Mogasale V, Neuzil KM, Qadri F, Adu-Sarkodie Y, Owusu-Dabo E, Clemens J, Marks F.
Haselbeck AH, et al. Among authors: mojares zr.
Vaccines (Basel). 2021 Mar 19;9(3):281. doi: 10.3390/vaccines9030281.
Vaccines (Basel). 2021.
PMID: 33808924
Free PMC article.
Item in Clipboard
Cite
Cite